Methodological issues in newborn screening evaluation with special reference to congenital adrenal hyperplasia

Area of Science:

• Medical Genetics
• Public Health
• Neonatal Care

Background:

• Newborn screening is mandatory in the US, with increasing genetic tests and program costs.
• Evaluating these programs is essential for evidence-based decision-making.
• Congenital adrenal hyperplasia serves as a case study for screening evaluation challenges.

Purpose of the Study:

• To discuss methodological problems in applying universal criteria to newborn screening.
• To highlight issues like altering disease natural history and lack of consensus.
• To propose a framework for evaluating and comparing candidate newborn screening programs.

Main Methods:

• Analysis of methodological challenges in applying established screening evaluation criteria.
• Review of issues including disease natural history alteration and definitional inconsistencies.
• Identification of the need for longitudinal studies on screen-detected neonates.

Main Results:

• Standard screening evaluation criteria face challenges when applied to specific disorders.
• Altering disease natural history, lack of consensus, and insufficient longitudinal data impede evaluation.
• Current methods are insufficient for comparing and evaluating candidate newborn screening programs.

Conclusions:

• Formal national trials are recommended for evaluating and comparing candidate newborn screening programs.
• Clear responsibilities for data submission and analysis among stakeholders are needed.
• This approach will ensure evidence-based decision-making for public health screening initiatives.